Introducing OpenBioLLM-Llama3-70B & 8B: Saama’s AI Research Lab Released the Most Openly Available Medical-Domain LLMs to Date
Related Posts
Rybrevant with Leclaza Shows Significantly Improved Progression-Free Survival vs. Tagrisso Treating EGFR-Mutated Advanced NSCLC
Image credit: Sebastian Kaulitzki | stock.adobe.com The combination of Rybrevant (amivantamab-vmjw; Janssen Pharmaceutical) with Leclaza (lazertinib; Johnson & Johnson) produced…
FDA Grants Clearance to ‘Pioneering’ Non-Invasive Treatment for Painful Diabetic Neuropathy
Image credit: AIGen | stock.adobe.com The FDA has granted clearance to Neuralace Medical’s Axon Therapy, which is a noninvasive treatment…
A New Horizon for Data Sharing with Truthful Statistics
Image Credit: © Egor – stock.adobe.com The need to preserve data quality, uphold transparency, and mitigate potential biases is underlined…